首页 | 本学科首页   官方微博 | 高级检索  
     

肝转移瘤立体定向适形放疗临床分析
引用本文:郑瑞锋,苏欣,闫敏,百宏灿,聂晓光,于丹丹,黄凯. 肝转移瘤立体定向适形放疗临床分析[J]. 中国现代医学杂志, 2005, 15(21): 3330-3332
作者姓名:郑瑞锋  苏欣  闫敏  百宏灿  聂晓光  于丹丹  黄凯
作者单位:武警河南总队医院,肿瘤科,河南,郑州,450052
摘    要:
目的探讨立体定向适形放疗对肝转移瘤的疗效。方法对63例共121个转移病灶实施立体定向适形放疗,肿瘤中心剂量30~68GY,每次5~8GY,分6~8次,每周2、3次,疗程2~4周,计划靶区体积1.8~130.0cm3,设伊8个非共面照射野,利用同步铅挡块,80%等剂量线包括靶区边界。结果肿瘤消退有效率(CR+PR)86.8%(105/121),其中CR33.1%(40/121),PR53.7%(65/121),NC10.7%(13/121),PD2.5%(3/121)。肿瘤剂量30-45GY组:CR14.3%(3/21),50-58GY组:CR29.4%(20/68)(P〈O.05);60-68GY组,CR53.2%(17/32)(P〈0.05)。原发灶病理学类型为鳞癌CR73.3%(11/15);病理学类型为软组织来源CR12.5%(1/8)(P〈0.05)。低分化组CR47.2%(17/36)、中高分化组CR27.1%(23/85)(P〈0.05)。肿瘤直径〈2.0cm组CR75.9%(22/29);肿瘤直径2.0-5.0cm组CR24.2%(15/62)(P〈0.05);肿瘤直径〉5.0cmCR10.0%(3/30)(P〈0.05)。结论立体定向适行放疗为肝转移瘤治疗的有效手段,疗效与肿瘤剂量、原发灶病理学类型及肿瘤体积大小关系密切。

关 键 词:肝转移瘤 立体定向 适形放疗
文章编号:1005-8982(2005)21-3330-03
收稿时间:2004-12-20
修稿时间:2004-12-20

Clinical analysis of stereotactic conformanl radiotherapy for metastases liver carcinoma
ZHENG Rui-feng,SU Xin,YAN Min,BAI Hong-can,NIE Xiao-guang,YU Dan-dan,HUANG Kai. Clinical analysis of stereotactic conformanl radiotherapy for metastases liver carcinoma[J]. China Journal of Modern Medicine, 2005, 15(21): 3330-3332
Authors:ZHENG Rui-feng  SU Xin  YAN Min  BAI Hong-can  NIE Xiao-guang  YU Dan-dan  HUANG Kai
Abstract:
[Objective] To detect the treatment effect of stereotactic conformal radiotherapy for metastases liver carcinoma. [Methods] 63 patients with 121 metastases 30~68 GY, 5~8 GY per times, 6~8 times per course, 2~3 times per week, 2~4week per course, planning target volume(PTV)1.8~130.0 cm3. Among 6~8 irradiation static confrmai fields are delivered. The clinical tumor volume was totally encompassed within the exposure by 80% of the prescribed epual does. [Result] The total effective rate of the treatment, was 86.8%(105/121), CR 33.1%, PR 53.7%(65/121), NC 10.7%(13/121), PD 2.5%(3/121). The group that tumor center does was 30~45 GY: CP 14.3%(3/12), The group that tumor center does was 50~58 GY: CR 29.4%(20/68)(P <0.05). The group that tumor center does is 60-68GY: CR 53.2% (17/32)(P <0.05). The group that primary tumor pathological types was squamous cell carcinoma: CR 73.3%(11/15), The group that primary tumor pathological types soft-tissue cell carcinoma: CR 12.5%(1/8) (P <0.05). The group that low-differentianed cell: CR 47.2%(17/36), The group that middle or hight-differentiated cell:CR 27.1%(23/85) (P <0.05). The group that tumor less than 2.0 cm in diameter: CR 75.9%(22/29), the group that tumor from 2.0 to 5.0 cm in diameter: CR 24.2% (15/62) (P <0.05). The group that rumor more than 5.0 cm in diameter: CR 10.0%(3/30) (P <0.05). [Conclusions] The stereotactic conformal radiotherapy is a effective methods for metastases liver carcinoma. The effect is relate to the tumor center does the primary pathological types and the tumor volume.
Keywords:metastases liver carcinoma   stereotactic   conformal radiotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号